Patents by Inventor Musa Nur GABERE

Musa Nur GABERE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antiviral peptides for treatment of the middle east respiratory syndrome
    Patent number: 11364276
    Abstract: A peptide that binds to the Si spike protein of Middle East Respiratory syndrome coronavirus or MERS-CoV and a method for inhibiting infection of a subject exposed to or having MERS-CoV by administering the peptide.
    Type: Grant
    Filed: March 26, 2020
    Date of Patent: June 21, 2022
    Assignees: National Guard Health Affairs, King Abdullah International Medical Research Center, King Saud bin Abdulaziz University for Health Sciences
    Inventors: Musa Nur Gabere, Sabeena Mustafa, Hanan Balkhy, Mohamed Hussein, Ibraheem Abdulaziz Bushnak
  • ANTIVIRAL PEPTIDES FOR TREATMENT OF THE MIDDLE EAST RESPIRATORY SYNDROME
    Publication number: 20200306338
    Abstract: A peptide that binds to the Si spike protein of Middle East Respiratory syndrome coronavirus or MERS-CoV and a method for inhibiting infection of a subject exposed to or having MERS-CoV by administering the peptide.
    Type: Application
    Filed: March 26, 2020
    Publication date: October 1, 2020
    Applicants: National Guard Health Affairs, King Saud bin Abdulaziz University for Health Sciences, King Abdullah International Medical Research Center
    Inventors: Musa Nur GABERE, Sabeena MUSTAFA, Hanan BALKHY, Mohamed HUSSEIN, Ibraheem Abdulaziz BUSHNAK